Teva Pharmaceutical Industries income from continuous operations for the twelve months ending June 30, 2024 was $-0.749B, a 69.38% decline year-over-year.
Teva Pharmaceutical Industries annual income from continuous operations for 2023 was $-0.615B, a 75.39% decline from 2022.
Teva Pharmaceutical Industries annual income from continuous operations for 2022 was $-2.499B, a 648.03% decline from 2021.
Teva Pharmaceutical Industries annual income from continuous operations for 2021 was $0.456B, a 111.12% decline from 2020.
Teva Pharmaceutical Industries Income from Continuous Operations 2010-2024 | TEVA